Table of Contents China Overactive Bladder Therapeutics Market Report 2012-2023 1 Overactive Bladder Therapeutics Overview 1.1 Product Overview and Scope of Overactive Bladder Therapeutics 1.2 Classification of Overactive Bladder Therapeutics by Product Category 1.2.1 China Overactive Bladder Therapeutics Sales (K Units) Comparison by Types (2012-2023) 1.2.2 China Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 1.2.3 Anti-Muscarinic Agent 1.2.4 Beta-3-Adrenergic Receptor Agonist 1.2.5 Others 1.3 China Overactive Bladder Therapeutics Market by Application/End Users 1.3.1 China Overactive Bladder Therapeutics (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Medical Care 1.3.3 Medical Research 1.3.4 Others 1.4 China Overactive Bladder Therapeutics Market by Region 1.4.1 China Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 South China Status and Prospect (2012-2023) 1.4.3 East China Status and Prospect (2012-2023) 1.4.4 Southwest China Status and Prospect (2012-2023) 1.4.5 Northeast China Status and Prospect (2012-2023) 1.4.6 North China Status and Prospect (2012-2023) 1.4.7 Central China Status and Prospect (2012-2023) 1.4.8 Northwest China Status and Prospect (2012-2023) 1.5 China Sales and Revenue ofSales and Revenue of Overactive Bladder Therapeutics (2012-2023) 1.5.1 China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) 1.5.2 China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Overactive Bladder Therapeutics 2.2 Raw Material Analysis of Overactive Bladder Therapeutics 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Overactive Bladder Therapeutics 2.4 Other Costs Analysis of Overactive Bladder Therapeutics 2.5 Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics 2.6 Manufacturing Process Analysis of Overactive Bladder Therapeutics 2.7 Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers in 2018 2.8 Downstream Buyers 3 China Overactive Bladder Therapeutics Players/Suppliers Profiles and Sales Data 3.1 Actavis 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Actavis Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Actavis Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.2 Allergan 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Allergan Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Allergan Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.3 Astellas Pharma 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Astellas Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Astellas Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.4 Pfizer 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Pfizer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Pfizer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.5 Addex Pharmaceuticals Ltd 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Addex Pharmaceuticals Ltd Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.6 Bayer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Bayer Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Bayer Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.7 Elbion 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Elbion Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Elbion Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.8 Ipsen 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Ipsen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Ipsen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.9 Janssen 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Janssen Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Janssen Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 3.10 Kissei Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Overactive Bladder Therapeutics Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Kissei Pharma Different Types of Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Kissei Pharma Overactive Bladder Therapeutics Volume in Different Applications and Its Application Share 4 China Overactive Bladder Therapeutics Competition by Players/Manufacturers, Region, Type and Application 4.1 China Overactive Bladder Therapeutics Market Competition by Players/Manufacturers 4.1.1 China Overactive Bladder Therapeutics Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 China Overactive Bladder Therapeutics Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 China Overactive Bladder Therapeutics Sales and Revenue by Type 4.2.1 China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 China Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 China Overactive Bladder Therapeutics Sales and Revenue by Application 4.3.1 China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 China Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 China Overactive Bladder Therapeutics Sales (K Units) by Application 5 South China Overactive Bladder Therapeutics (Sales, Revenue and Price) 5.1 South China Overactive Bladder Therapeutics Sales and Value (2012-2017) 5.1.1 South China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 5.1.2 South China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 5.1.3 South China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 5.2 South China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 5.3 South China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 6 East China Overactive Bladder Therapeutics (Sales, Revenue and Price) 6.1 East China Overactive Bladder Therapeutics Sales and Value (2012-2017) 6.1.1 East China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 6.1.2 East China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 6.1.3 East China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 6.2 East China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 6.3 East China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 7 Southwest China Overactive Bladder Therapeutics (Sales, Revenue and Price) 7.1 Southwest China Overactive Bladder Therapeutics Sales and Value (2012-2017) 7.1.1 Southwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 7.1.2 Southwest China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 7.1.3 Southwest China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 7.2 Southwest China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 7.3 Southwest China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 8 Northeast China Overactive Bladder Therapeutics (Sales, Revenue and Price) 8.1 Northeast China Overactive Bladder Therapeutics Sales and Value (2012-2017) 8.1.1 Northeast China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Northeast China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 8.1.3 Northeast China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 8.2 Northeast China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 8.3 Northeast China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 9 North China Overactive Bladder Therapeutics (Sales, Revenue and Price) 9.1 North China Overactive Bladder Therapeutics Sales and Value (2012-2017) 9.1.1 North China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 9.1.2 North China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 9.1.3 North China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 9.2 North China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 9.3 North China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 10 Central China Overactive Bladder Therapeutics (Sales, Revenue and Price) 10.1 Central China Overactive Bladder Therapeutics Sales and Value (2012-2017) 10.1.1 Central China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Central China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 10.1.3 Central China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 10.2 Central China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 10.3 Central China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 11 Northwest China Overactive Bladder Therapeutics (Sales, Revenue and Price) 11.1 Northwest China Overactive Bladder Therapeutics Sales and Value (2012-2017) 11.1.1 Northwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Northwest China Overactive Bladder Therapeutics Revenue and Growth Rate (2012-2017) 11.1.3 Northwest China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) 11.2 Northwest China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Type 11.3 Northwest China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 China Overactive Bladder Therapeutics Market Forecast (2018-2023) 13.1 China Overactive Bladder Therapeutics Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 China Overactive Bladder Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 China Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) 13.2 China Overactive Bladder Therapeutics Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 China Overactive Bladder Therapeutics Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 South China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 East China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Southwest China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Northeast China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 Southwest China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Central China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Northwest China Overactive Bladder Therapeutics Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 China Overactive Bladder Therapeutics Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 China Overactive Bladder Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 China Overactive Bladder Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 China Overactive Bladder Therapeutics Price Forecast by Type (2018-2023) 13.4 China Overactive Bladder Therapeutics Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure China Market Size (Million USD) Comparison 2012-2023 Table China Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Table China Overactive Bladder Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table China Overactive Bladder Therapeutics Sales (K Units) by Application (2016-2023) Figure Product Picture of Overactive Bladder Therapeutics Table China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share by Types in 2017 Figure Anti-Muscarinic Agent Picture Figure Beta-3-Adrenergic Receptor Agonist Picture Figure Others Picture Table China Overactive Bladder Therapeutics Sales (K Units) Comparison by Applications (2012-2023) Figure China Sales Market Share of Overactive Bladder Therapeutics by Applications in 2017 Figure Medical Care Picture Figure Medical Research Picture Figure Others Picture Table China Market Overactive Bladder Therapeutics Revenue (Million USD) Comparison by Regions 2012-2023 Figure South China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure East China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Southwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Northeast China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure North China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Central China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure Northwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Overactive Bladder Therapeutics Table Industry News List of Overactive Bladder Therapeutics Figure Industry Chain Structure of Overactive Bladder Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Overactive Bladder Therapeutics in 2017 Figure Manufacturing Process Analysis of Overactive Bladder Therapeutics Table Raw Materials Sources of Overactive Bladder Therapeutics Major Manufacturers China Table Major Buyers of Overactive Bladder Therapeutics Table Actavis Basic Information List Table Actavis Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Actavis Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Actavis Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Actavis Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Actavis Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Allergan Basic Information List Table Allergan Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Allergan Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Allergan Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Allergan Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Allergan Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Astellas Pharma Basic Information List Table Astellas Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Astellas Pharma Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Astellas Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Pfizer Basic Information List Table Pfizer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Pfizer Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Pfizer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Addex Pharmaceuticals Ltd Basic Information List Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Addex Pharmaceuticals Ltd Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Bayer Basic Information List Table Bayer Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Bayer Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Bayer Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Bayer Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Elbion Basic Information List Table Elbion Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Elbion Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Elbion Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Elbion Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Elbion Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Ipsen Basic Information List Table Ipsen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Ipsen Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Ipsen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Ipsen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Janssen Basic Information List Table Janssen Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Janssen Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Janssen Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Janssen Overactive Bladder Therapeutics Volume in Others and Its Application Share Table Company Kissei Pharma Basic Information List Table Company Kissei Pharma Overactive Bladder Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales Growth Rate (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Sales China Market Share (%) (2012-2017) Figure Company Kissei Pharma Overactive Bladder Therapeutics Revenue China Market Share (%) (2012-2017) Table Anti-Muscarinic Agent Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Beta-3-Adrenergic Receptor Agonist Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Others Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Care and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Medical Research and Its Application Share Table Company Kissei Pharma Overactive Bladder Therapeutics Volume in Others and Its Application Share Table China Overactive Bladder Therapeutics Sales (K Units) by Players/Manufacturers (2012-2017) Table China Overactive Bladder Therapeutics Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 China Overactive Bladder Therapeutics Sales Market Share (%) by Players/Manufacturers Figure 2017 China Overactive Bladder Therapeutics Sales Share by Players/Manufacturers Table China Overactive Bladder Therapeutics Revenue (Million USD) by Players/Manufacturers (2012-2017) Table China Overactive Bladder Therapeutics Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 China Overactive Bladder Therapeutics Revenue Market Share (%) Players Figure 2017 China Overactive Bladder Therapeutics Revenue Market Share (%) Players Table China Overactive Bladder Therapeutics Sales (K Units) and Market Share (%) by Type (2012-2017) Table China Overactive Bladder Therapeutics Sales Share by Type (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure China Overactive Bladder Therapeutics Sales Growth Rate (%) by Type (2012-2017) Table China Overactive Bladder Therapeutics Revenue (Million USD) and Market Share (%) Type (2012-2017) Table China Overactive Bladder Therapeutics Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Type (2012-2017) Figure China Overactive Bladder Therapeutics Revenue Growth Rate by Type (2012-2017) Table China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Regions (2012-2017) Table China Overactive Bladder Therapeutics Sales Share by Regions (2012-2017) Figure Sales Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure China Overactive Bladder Therapeutics Sales Market Share by Regions in 2017 Table China Overactive Bladder Therapeutics Revenue (Million USD) and Market Share by Regions (2012-2017) Table China Overactive Bladder Therapeutics Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Overactive Bladder Therapeutics by Regions (2012-2017) Figure China Overactive Bladder Therapeutics Revenue Market Share by Regions in 2017 Table China Overactive Bladder Therapeutics Sales (K Units) and Market Share by Application (2012-2017) Table China Overactive Bladder Therapeutics Sales Share (%) by Application (2012-2017) Figure China Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure China Overactive Bladder Therapeutics Sales Market Share by Application (2012-2017) Figure South China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017) Figure South China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table South China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table South China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure South China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table South China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table South China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure South China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure East China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure East China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure East China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table East China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table East China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure East China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table East China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table East China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure East China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Southwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Southwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southwest China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Southwest China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Southwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Southwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Southwest China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Southwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Southwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Northeast China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Northeast China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Northeast China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Northeast China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Northeast China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Northeast China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Northeast China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Central China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Central China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Central China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Central China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Central China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Central China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Central China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Central China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Central China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure North China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure North China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure North China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table North China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table North China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure North China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table North China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table North China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure North China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Figure Northwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (2012-2017) Figure Northwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northwest China Overactive Bladder Therapeutics Sales Price (USD/Unit) Trend (2012-2017) Table Northwest China Overactive Bladder Therapeutics Sales (K Units) by Type (2012-2017) Table Northwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type (2012-2017) Figure Northwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Type in 2017 Table Northwest China Overactive Bladder Therapeutics Sales (K Units) by Applications (2012-2017) Table Northwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications (2012-2017) Figure Northwest China Overactive Bladder Therapeutics Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Overactive Bladder Therapeutics Price and Trend Forecast (2018-2023) Table China Overactive Bladder Therapeutics Sales (K Units) Forecast by Regions (2018-2023) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure China Overactive Bladder Therapeutics Sales (K Units) Market Share Forecast by Regions in 2023 Table China Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023) Figure China Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions (2018-2023) Figure China Overactive Bladder Therapeutics Revenue Market Share Forecast by Regions in 2023 Figure South China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure East China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure East China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure North China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Central China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Central China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Overactive Bladder Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Overactive Bladder Therapeutics Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table China Overactive Bladder Therapeutics Sales (K Units) Forecast by Type (2018-2023) Figure China Overactive Bladder Therapeutics Sales Market Share Forecast by Type (2018-2023) Table China Overactive Bladder Therapeutics Revenue (Million USD) Forecast by Type (2018-2023) Figure China Overactive Bladder Therapeutics Revenue Market Share Forecast by Type (2018-2023) Table China Overactive Bladder Therapeutics Price (USD/Unit) Forecast by Type (2018-2023) Table China Overactive Bladder Therapeutics Sales (K Units) Forecast by Application (2018-2023) Figure China Overactive Bladder Therapeutics Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Actavis Allergan Astellas Pharma Pfizer Addex Pharmaceuticals Ltd Bayer Elbion Ipsen Janssen Kissei Pharma